{"count": 6, "results": [{"_id": "35564864", "pmid": 35564864, "pmcid": "PMC9103656", "title": "Prepregnancy Polycystic Ovary Syndrome as a Risk Factor of Subsequent Preterm Labor: A National Population-Based Cohort Study", "journal": "Int J Environ Res Public Health", "authors": ["Pan ML", "Chen LR", "Chen KH"], "date": "2022-04-30T00:00:00Z", "doi": "10.3390/ijerph19095470", "meta_date_publication": "2022 Apr 30", "meta_volume": "19", "meta_issue": "9", "meta_pages": "", "score": 50283.76, "text_hl": "The risk of subsequent @<m>DISEASE_Obstetric_Labor_Premature</m> @DISEASE_MESH:D007752 @@@preterm labor@@@ was reduced by about 10% for the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ subgroup compared with the non-@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ subgroup. ", "citations": {"NLM": "Pan ML, Chen LR, Chen KH. Prepregnancy Polycystic Ovary Syndrome as a Risk Factor of Subsequent Preterm Labor: A National Population-Based Cohort Study Int J Environ Res Public Health. 2022 Apr 30;19(9):. PMID: 35564864", "BibTeX": "@article{35564864, title={Prepregnancy Polycystic Ovary Syndrome as a Risk Factor of Subsequent Preterm Labor: A National Population-Based Cohort Study}, author={Pan ML and Chen LR and Chen KH}, journal={Int J Environ Res Public Health}, volume={19}, number={9}}"}}, {"_id": "23162354", "pmid": 23162354, "pmcid": "PMC3493830", "title": "Effects of metformin use in pregnant patients with polycystic ovary syndrome", "journal": "J Hum Reprod Sci", "authors": ["Kumar P", "Khan K"], "date": "2012-05-01T00:00:00Z", "doi": "10.4103/0974-1208.101012", "meta_date_publication": "2012 May", "meta_volume": "5", "meta_issue": "2", "meta_pages": "166-9", "score": 50075.258, "text_hl": "The study found that the group, which continued @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use throughout the entire pregnancy, had diminished incidences of @DISEASE_Fetal_Growth_Retardation @DISEASE_MESH:D005317 @@@fetal growth restriction@@@, @<m>DISEASE_Obstetric_Labor_Premature</m> @DISEASE_MESH:D007752 @@@preterm labor@@@, and increased live birth rates. ", "citations": {"NLM": "Kumar P, Khan K. Effects of metformin use in pregnant patients with polycystic ovary syndrome J Hum Reprod Sci. 2012 May;5(2):166-9. PMID: 23162354", "BibTeX": "@article{23162354, title={Effects of metformin use in pregnant patients with polycystic ovary syndrome}, author={Kumar P and Khan K}, journal={J Hum Reprod Sci}, volume={5}, number={2}, pages={166-9}}"}}, {"_id": "27603343", "pmid": 27603343, "pmcid": "PMC5023865", "title": "Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome", "journal": "Medicine (Baltimore)", "authors": ["Zeng XL", "Zhang YF", "Tian Q", "Xue Y", "An RF"], "date": "2016-09-01T00:00:00Z", "doi": "10.1097/MD.0000000000004526", "meta_date_publication": "2016 Sep", "meta_volume": "95", "meta_issue": "36", "meta_pages": "e4526", "score": 50071.73, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ treatment in @SPECIES_9606 @@@women@@@ with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ throughout pregnancy could increase the possibility of term delivery, @DISEASE_Vaginitis @DISEASE_MESH:D014627 @@@VD@@@ and reduce the risk of @DISEASE_Abortion_Spontaneous @DISEASE_MESH:D000022 @@@EPL@@@, @<m>DISEASE_Obstetric_Labor_Premature</m> @DISEASE_MESH:D007752 @@@preterm labor@@@, pregnancy complications such as @DISEASE_Diabetes_Gestational @DISEASE_MESH:D016640 @@@GDM@@@ and @DISEASE_Hypertension_Pregnancy_Induced @DISEASE_MESH:D046110 @@@PIH@@@, with no serious side effects. ", "citations": {"NLM": "Zeng XL, Zhang YF, Tian Q, Xue Y, An RF. Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome Medicine (Baltimore). 2016 Sep;95(36):e4526. PMID: 27603343", "BibTeX": "@article{27603343, title={Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome}, author={Zeng XL and Zhang YF and Tian Q and Xue Y and An RF}, journal={Medicine (Baltimore)}, volume={95}, number={36}, pages={e4526}}"}}, {"_id": "17628554", "pmid": 17628554, "title": "Triplet pregnancy after metformin in a woman with polycystic ovary syndrome.", "journal": "Fertil Steril", "authors": ["Clapauch R", "Mattos TM"], "date": "2008-05-01T00:00:00Z", "doi": "10.1016/j.fertnstert.2007.05.034", "meta_date_publication": "2008 May", "meta_volume": "89", "meta_issue": "5", "meta_pages": "1260.e1-1260.e2", "score": 50057.74, "text_hl": "RESULT(S): Pregnancy developed up to @<m>DISEASE_Obstetric_Labor_Premature</m> @DISEASE_MESH:D007752 @@@premature labor@@@ at 31 weeks. ", "citations": {"NLM": "Clapauch R, Mattos TM. Triplet pregnancy after metformin in a woman with polycystic ovary syndrome. Fertil Steril. 2008 May;89(5):1260.e1-1260.e2. PMID: 17628554", "BibTeX": "@article{17628554, title={Triplet pregnancy after metformin in a woman with polycystic ovary syndrome.}, author={Clapauch R and Mattos TM}, journal={Fertil Steril}, volume={89}, number={5}, pages={1260.e1-1260.e2}}"}}, {"_id": "23886298", "pmid": 23886298, "title": "Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review.", "journal": "Metabolism", "authors": ["Lautatzis ME", "Goulis DG", "Vrontakis M"], "date": "2013-11-01T00:00:00Z", "doi": "10.1016/j.metabol.2013.06.006", "meta_date_publication": "2013 Nov", "meta_volume": "62", "meta_issue": "11", "meta_pages": "1522-34", "score": 50047.73, "text_hl": "The use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ throughout pregnancy in @SPECIES_9606 @@@women@@@ with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovary syndrome@@@ reduces the rates of early @DISEASE_Abortion_Spontaneous @DISEASE_MESH:D000022 @@@pregnancy loss@@@ and @<m>DISEASE_Obstetric_Labor_Premature</m> @DISEASE_MESH:D007752 @@@preterm labor@@@ and protects against fetal @DISEASE_Fetal_Growth_Retardation @DISEASE_MESH:D005317 @@@growth restriction@@@. ", "citations": {"NLM": "Lautatzis ME, Goulis DG, Vrontakis M. Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review. Metabolism. 2013 Nov;62(11):1522-34. PMID: 23886298", "BibTeX": "@article{23886298, title={Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review.}, author={Lautatzis ME and Goulis DG and Vrontakis M}, journal={Metabolism}, volume={62}, number={11}, pages={1522-34}}"}}, {"_id": "20458488", "pmid": 20458488, "title": "Polycystic ovarian syndrome and pregnancy outcome.", "journal": "Arch Gynecol Obstet", "authors": ["Iavazzo C", "Vitoratos N"], "date": "2010-09-01T00:00:00Z", "doi": "10.1007/s00404-010-1495-0", "meta_date_publication": "2010 Sep", "meta_volume": "282", "meta_issue": "3", "meta_pages": "235-9", "score": 50041.438, "text_hl": "Furthermore, @SPECIES_9606 @@@women@@@ with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ seem to experience increased risk of cesarean delivery while their newborns face increased perinatal morbidity and mortality. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ use seems to reduce the risk of @DISEASE_Obstetric_Labor_Complications @DISEASE_MESH:D007744 @@@obstetrical complications@@@; however, prospective studies are necessary on the field. ", "citations": {"NLM": "Iavazzo C, Vitoratos N. Polycystic ovarian syndrome and pregnancy outcome. Arch Gynecol Obstet. 2010 Sep;282(3):235-9. PMID: 20458488", "BibTeX": "@article{20458488, title={Polycystic ovarian syndrome and pregnancy outcome.}, author={Iavazzo C and Vitoratos N}, journal={Arch Gynecol Obstet}, volume={282}, number={3}, pages={235-9}}"}}]}